Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
424studies shown
Showing 401-424 of 424
CompletedNCT03437772

Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 7 Years to 15 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
ADHD
CompletedNCT03878251

Outcomes Measures in Intellectual Disability

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.

ADHDOtherOver 6 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
ADHD
TerminatedNCT03481959

Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 12 Years to 25 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
ADHD
TerminatedNCT03942835

Psychometric Validation of the Competitive Attention Test

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 90 Years
Countries
France
Sponsor
Hospices Civils de Lyon
Condition
ADHD
CompletedNCT01244490

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Austria, Canada, France, Germany, Ireland, Italy, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT03436017

Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 15 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
ADHD
CompletedNCT01500694

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT00763971

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

This study exists to explore whether the medication Lisdexamfetamine could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT00784654

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

This study exists to understand how the medication LDX holds up over time after the earliest research stage. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, France, Germany, Hungary, Italy, Poland, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT04188626

Identification of Biomarkers to Predict Driver Take-over Control Quality

This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 20 Years to 75 Years
Countries
France
Sponsor
PSA Automobiles S.A.
Condition
ADHD
CompletedNCT04412499

Study of the Link Between Psychosocial Treatments and the Need of Pharmacological Treatments in Children With Attention Deficit Hyperactivity Disorder

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 18 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
ADHD
CompletedNCT01821170

Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive Psychotherapy

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

ADHDOtherFrom 7 Years to 11 Years
Countries
France
Sponsor
University Hospital, Bordeaux
Condition
ADHD
CompletedNCT03289793

NEUROFEEDBACK on Event-Related Potential (ERP)

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 17 Years
Countries
France
Sponsor
Hospices Civils de Lyon
Condition
ADHD
CompletedNCT02560454

Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 12 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
ADHD
CompletedNCT02217371

Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
University Hospital, Bordeaux
Condition
ADHD
CompletedNCT01553695

Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

ADHDOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
ADHD
CompletedNCT00700427

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 50 Years
Countries
Austria, Belgium, Finland, France, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Sponsor
Eli Lilly and Company
Condition
ADHD
CompletedNCT00714688

A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
Belgium, Denmark, Finland, France, Germany, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Sponsor
Janssen-Cilag International NV
Condition
ADHD
CompletedNCT00307684

Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to understand how the medication Protocol holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Protocol can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
France, Germany, Netherlands, Norway, Portugal, Spain, Switzerland
Sponsor
Janssen-Cilag International NV
Condition
ADHD
France | Clinical Trials | HopeStage Research